OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Perioperative immunotherapy for esophageal squamous cell carcinoma: Now and future
Yong Liu
World Journal of Gastroenterology (2023) Vol. 29, Iss. 34, pp. 5020-5037
Open Access | Times Cited: 13
Yong Liu
World Journal of Gastroenterology (2023) Vol. 29, Iss. 34, pp. 5020-5037
Open Access | Times Cited: 13
Showing 13 citing articles:
Phase I/II Trial of Perioperative Avelumab in Combination With Chemoradiation in the Treatment of Stage II/III Resectable Esophageal and Gastroesophageal Junction Cancer
Nataliya V. Uboha, Mustafa Basree, Jens C. Eickhoff, et al.
Journal of Surgical Oncology (2025)
Open Access
Nataliya V. Uboha, Mustafa Basree, Jens C. Eickhoff, et al.
Journal of Surgical Oncology (2025)
Open Access
Ursolic acid enhances radiosensitivity in esophageal squamous cell carcinoma by modulating p53/SLC7A11/GPX4 pathway-mediated ferroptosis
Nuran Bedolla, Linyu Liu, Xueting Liu, et al.
Toxicon (2025) Vol. 255, pp. 108233-108233
Closed Access
Nuran Bedolla, Linyu Liu, Xueting Liu, et al.
Toxicon (2025) Vol. 255, pp. 108233-108233
Closed Access
CCR7 in esophageal squamous cell carcinoma: an identification from single-cell and bulk transcriptome sequencing
Yang Yu, Qian Zhao, Hongguang Cui, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Yang Yu, Qian Zhao, Hongguang Cui, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Neoadjuvant chemoimmunotherapy for small cell carcinoma of the esophagus: Clinical efficacy and biomarker exploration
Junhan Wu, Xin Xia, Longlong Gong, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 2
Junhan Wu, Xin Xia, Longlong Gong, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 2
Tislelizumab induced dual organs dysfunction in a patient with advanced esophageal squamous cell carcinoma: a case report
Bo Yang, Wei Gou, Naiying Lan, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Bo Yang, Wei Gou, Naiying Lan, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Prospects for the clinical application of exosomal circular RNA in squamous cell carcinoma
Rongzhong Wang, Shi-Yan Wang, Hongbing Jiang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Rongzhong Wang, Shi-Yan Wang, Hongbing Jiang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Capivasertib reverses chemotherapy-induced esophageal cancer resistance via inhibiting Akt-associated Mcl-1 upregulation
Jindan Kai, Kai Kang, Zhixiao Jiang, et al.
Heliyon (2024) Vol. 10, Iss. 13, pp. e33567-e33567
Open Access | Times Cited: 1
Jindan Kai, Kai Kang, Zhixiao Jiang, et al.
Heliyon (2024) Vol. 10, Iss. 13, pp. e33567-e33567
Open Access | Times Cited: 1
From tumor microenvironment to emerging biomarkers: the reshaping of the esophageal squamous cell carcinoma tumor microenvironment by neoadjuvant chemotherapy combined with immunotherapy
Zhengzhou Qiu, Li Zhao, Xingfei Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Zhengzhou Qiu, Li Zhao, Xingfei Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Erdafitinib and checkpoint inhibitors for first-line and second-line immunotherapy of hepatic, gastrointestinal, and urinary bladder carcinomas: Recent concept
Mohamed Wishahi
World Journal of Hepatology (2024) Vol. 16, Iss. 4, pp. 490-493
Open Access
Mohamed Wishahi
World Journal of Hepatology (2024) Vol. 16, Iss. 4, pp. 490-493
Open Access
Identification of genome-wide copy number variation-driven subtypes for the treatment and prognostic prediction of esophageal carcinoma
Chao Zhao, Hui Han, Yushuang Tian, et al.
Heliyon (2024) Vol. 10, Iss. 19, pp. e38011-e38011
Open Access
Chao Zhao, Hui Han, Yushuang Tian, et al.
Heliyon (2024) Vol. 10, Iss. 19, pp. e38011-e38011
Open Access
Integrative Analysis and Validation of a Cancer-associated Fibroblasts Senescence-related Signature for Risk Stratification and Therapeutic Prediction in Esophageal Squamous Cell Carcinoma
Han Zhang, Kunqiao Hong, Qi Song, et al.
Journal of Cancer (2024) Vol. 15, Iss. 17, pp. 5742-5761
Open Access
Han Zhang, Kunqiao Hong, Qi Song, et al.
Journal of Cancer (2024) Vol. 15, Iss. 17, pp. 5742-5761
Open Access
Navigating new horizons in inflammatory bowel disease: Integrative approaches and innovations
Shi‐Yan Zhang
World Journal of Gastroenterology (2024) Vol. 30, Iss. 41, pp. 4411-4416
Closed Access
Shi‐Yan Zhang
World Journal of Gastroenterology (2024) Vol. 30, Iss. 41, pp. 4411-4416
Closed Access
Nomogram for predicting pathologic complete response following preoperative chemoradiotherapy in patients with esophageal squamous cell carcinoma
Young Seob Shin, Jeong Yun Jang, Ye Jin Yoo, et al.
Gastroenterology report (2023) Vol. 12
Open Access
Young Seob Shin, Jeong Yun Jang, Ye Jin Yoo, et al.
Gastroenterology report (2023) Vol. 12
Open Access
